July 2023 Report How Universal Health Coverage Can Increase Access to Sexual and Reproductive Health Services in Sub-Saharan Africa Nardos Hagos, Irum Taqi and Susheela Singh
July 2023 Report Publicly Funded Clinics Providing Contraceptive Services in Four US States: The Disruptions of the “Domestic Gag Rule” and COVID-19 Alicia VandeVusse, Jennifer Mueller, Ava Braccia, Samira M. Sackietey and Jennifer J. Frost
July 2023 Research Article Effects of the COVID-19 pandemic on publicly supported clinics providing contraceptive services in four US states Jennifer Mueller, Alicia VandeVusse, Samira M. Sackietey, Ava Braccia and Jennifer J. Frost Contraception: X
July 2023 News Release Trump Administration Restrictions on Public Funding for Sexual and Reproductive Health Care Disrupted Contraceptive Access in Four US States
June 2023 Policy Analysis Advancing Equity in a Post-Dobbs Landscape: Applying the Racial Equity and Policy Framework to the Work of the Guttmacher Institute Herminia Palacio and Aletha Y. Akers
June 2023 Opinion On Dobbs Anniversary, Donors Must Take the Long View in Response to Abortion-Access Crisis Jonathan Wittenberg and Wendy Sealey The Chronicle of Philanthropy
June 2023 Opinion One-year post-Roe, how can policymakers protect abortion access? Kelly Baden and Isabel Guarnieri Harvard Public Health Magazine
June 2023 Policy Analysis The State Abortion Policy Landscape One Year Post-Roe Kelly Baden and Jennifer Driver
June 2023 Policy Analysis As Many as 16% of People Having Abortions Do Not Identify as Heterosexual Women Doris W. Chiu, Emma Stoskopf-Ehrlich and Rachel K. Jones
June 2023 Opinion Anti-Abortion Politicians Never Intended to Support Women and Children Kelly Baden The Hill
May 2023 Research Article Primary and reproductive healthcare access and use among reproductive aged women and female family planning patients in 3 states Liza Fuentes, Ayana Douglas-Hall, Christina E. Geddes and Megan L. Kavanaugh PLOS ONE
May 2023 Policy Analysis Guttmacher Expert Testimony in Support of Approving Over-the-Counter Status for Opill Without an Age Restriction Megan L. Kavanaugh
